ClassID:

97305

C07K2317/82 - CPC Classification

Classification description:

Immunoglobulins specific features remaining in the (producing) cell, i.e. intracellular antibodies or intrabodies functional in the cytoplasm, the inner aspect of the cell membrane, the nucleus or the mitochondria

Recent Application in this class:
#1
20250376540
2025-12-11

Binding Proteins 1

#2
20250223341
2025-07-10

P97-BASE PROTAC ANTIBODY CONJUGATES AND METHODS OF USE

#3
20250101089
2025-03-27

TAU THERAPY

#4
20240409624
2024-12-12

ANTIBODIES

#5
20240101652
2024-03-28

THERAPEUTIC SINGLE DOMAIN ANTIBODY

#6
20230406960
2023-12-21

Binding proteins 1

#7
20220065850
2022-03-03

INTRABODIES TARGETING POST-TRANSLATIONAL MODIFICATIONS OF NATIVE PROTEINS AND METHOD FOR OBTAINING THEM

#8
20210238308
2021-08-05

ANTIGEN-BINDING MOLECULE SHOWING CHANGED HALF-LIFE IN CYTOPLASM

#9
20210122808
2021-04-29

Antibodies and fragments thereof that bind hepatitis B virus protein X

#10
20200339681
2020-10-29

ANTIBODY INHIBITING ACTIVATED RAS IN CELL BY INTERNALIZING INTO CYTOSOL OF CELL, AND USE THEREOF

#11
20200239597
2020-07-30

AN ANTI-APOPTOTIC FUNCTION OF PKM2 AND INTRACELLULARLY EXPRESSED SCFV ANTIBODIES

#12
20200216567
2020-07-09

Binding proteins 1

#13
20200165322
2020-05-28

IMMUNOGLOBULIN FRAMEWORKS WHICH DEMONSTRATE ENHANCED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND METHODS OF IDENTIFYING SAME

#14
20190361013
2019-11-28

Intrabodies targeting post-translational modifications of native proteins and method for obtaining them

#15
20190309052
2019-10-10

Antibodies and fragments thereof that bind hepatitis B virus protein X

#16
20190144566
2019-05-16

Cytosol-penetrating antibody and use thereof

#17
20190119361
2019-04-25

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

#18
20190091341
2019-03-28

Polyethylenimine (PEI)-polypeptide conjugates and methods of use thereof

#19
20170355756
2017-12-14

TDP-43-binding polypeptides useful for the treatment of neurodegenerative diseases

#20
20170218084
2017-08-03

Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same

#21
20170107272
2017-04-20

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

#22
20170073429
2017-03-16

Cell penetrating anti-guanosine antibody based therapy for cancers with Ras mutations

#23
20150366986
2015-12-24

Intranuclear protein transduction through a nucleoside salvage pathway

#24
20150057191
2015-02-26

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

#25
20150044700
2015-02-12

Anti-GAP43 antibody

#26
20140335568
2014-11-13

Nucleic acid assembly, vector, cell, methods and kit thereof

#27
20140234313
2014-08-21

Soluble polypeptides

#28
20110263829
2011-10-27

CELL-PENETRATING, SEQUENCE-SPECIFIC AND NUCLEIC ACID-HYDROLYZING ANTIBODY, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#29
20110159569
2011-06-30

ANTI-NUCLEIC ACID ANTIBODY INDUCING CELL DEATH OF CANCER CELLS AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME

#30
20100323905
2010-12-23

Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates

#31
20100196403
2010-08-05

ANTIBODY CONJUGATES FOR CIRCUMVENTING MULTI-DRUG RESISTANCE

#32
20100047230
2010-02-25

ANTI HER2/NEU ANTIBODY

#33
20090324579
2009-12-31

Anti-apoptotic protein antibodies

#34
20090078315
2009-03-26

ELECTRODE, METHOD OF MAKING SAME, PHOTOELECTRIC TRANSFER ELEMENT, METHOD OF MANUFACTURING SAME, ELECTRONIC DEVICE AND METHOD OF MANUFACTURING SAME

#35
20090004197
2009-01-01

Dek protein compositions and methods of using the same

#36
20080292618
2008-11-27

Intranuclear protein transduction through a nucleoside salvage pathway

#37
20080273660
2008-11-06

Compositions and Methods for Modulating DNA Repair

#38
20080025969
2008-01-31

Treatment of Neurodegenerative Diseases by the Use of Gpr49

#39
20070258897
2007-11-08

Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells

#40
20070232520
2007-10-04

MODULATOR OF TNF/NGF SUPERFAMILY RECEPTORS AND SOLUBLE OLIGOMERIC TNF/NGF SUPERFAMILY RECEPTORS

#41
20070141025
2007-06-21

Compositions and methods for cancer immunotherapy

#42
20070125418
2007-06-07

Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same

#43
20070065890
2007-03-22

Method for promoting formation of facultative heterochromatin

#44
20060147997
2006-07-06

PenetraBodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases

#45
20060035320
2006-02-16

Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same

#46
20050255113
2005-11-17

Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders

#47
20050226879
2005-10-13

Methods and compositions related to inhibiting nuclear envelope breakdown

#48
20050226863
2005-10-13

Single-domain antibodies and uses thereof

#49
20050220796
2005-10-06

Compositions and methods for modulating DNA repair

#50
20050208058
2005-09-22

Compositions and methods for modulating cell division